Study smarter with Fiveable
Get study guides, practice questions, and cheatsheets for all your subjects. Join 500,000+ students with a 96% pass rate.
When you're tested on pharmacology, you're not just being asked to list administration routes—you're being evaluated on whether you understand why a clinician would choose one route over another. The key principles at play here include bioavailability (how much drug actually reaches systemic circulation), onset of action (how quickly effects begin), and first-pass metabolism (the liver's processing of drugs before they reach the bloodstream). These concepts determine everything from emergency treatment protocols to chronic disease management.
Think of administration routes as a decision tree: Does the patient need immediate effects or sustained release? Can they swallow? Do we want local or systemic effects? Does the drug survive the GI tract? Don't just memorize that nitroglycerin goes under the tongue—know that it's given sublingually because it would be destroyed by first-pass metabolism if swallowed. That's the level of understanding that earns full credit on exams.
First-pass metabolism occurs when drugs absorbed from the GI tract pass through the liver before reaching systemic circulation, often significantly reducing bioavailability. These routes deliver drugs directly to the bloodstream, avoiding hepatic processing entirely.
Compare: Sublingual vs. Transdermal—both bypass first-pass metabolism, but sublingual provides rapid onset (emergency use) while transdermal provides sustained delivery (chronic conditions). If an exam question involves a patient needing immediate angina relief, sublingual is your answer; for chronic pain management, think transdermal.
Parenteral administration refers to any route that bypasses the gastrointestinal tract entirely. These injectable routes offer predictable absorption and are essential when oral administration is impossible or inadequate.
Compare: IV vs. IM vs. SC—all bypass first-pass metabolism, but differ in onset (IV: immediate; IM: 10-30 min; SC: slower) and duration. IV is for emergencies and precise control; IM for depot injections and vaccines; SC for patient self-administration of chronic medications like insulin.
Enteral administration involves the gastrointestinal system. While convenient and cost-effective, these routes subject drugs to digestive enzymes, variable pH, and first-pass metabolism—all of which affect bioavailability.
Compare: Oral vs. Rectal—both are enteral routes, but rectal partially avoids first-pass metabolism and works when patients cannot swallow. However, rectal absorption is less predictable and patient acceptance is lower. Exam tip: rectal is your answer when a question describes a vomiting patient who needs systemic medication.
These routes deliver medication directly to the site of action, minimizing systemic exposure and side effects. The goal is therapeutic effect at the application site rather than throughout the body.
Compare: Topical vs. Transdermal—both applied to skin, but with opposite goals. Topical aims for local effect with minimal systemic absorption; transdermal uses the skin as a portal for systemic delivery. Don't confuse them on exams—a corticosteroid cream is topical; a fentanyl patch is transdermal.
The lungs offer an enormous surface area (approximately 70 square meters) with thin membranes and rich blood supply, enabling rapid absorption for both local respiratory effects and systemic delivery.
Compare: Inhalation vs. IV—both provide rapid onset, but inhalation is preferred for respiratory conditions because it delivers drug directly to the target organ at lower doses. IV would expose the entire body to medication just to treat the lungs. However, for systemic emergencies, IV remains faster and more reliable.
| Concept | Best Examples |
|---|---|
| Bypasses first-pass metabolism | Sublingual, buccal, transdermal, IV, IM, SC, intranasal, inhalation |
| Immediate onset (emergency use) | IV, sublingual, inhalation |
| Sustained/controlled release | Transdermal patches, IM depot injections, SC |
| Self-administration friendly | Oral, SC, transdermal, inhalation |
| When patient cannot swallow | IV, IM, SC, rectal, transdermal |
| Local effect with minimal systemic exposure | Topical, ophthalmic, otic, vaginal, inhalation |
| 100% bioavailability | IV only |
| Affected by first-pass metabolism | Oral (most significantly), rectal (partially) |
A patient experiencing an acute angina attack needs immediate relief. Why is nitroglycerin given sublingually rather than orally, and what pharmacokinetic principle does this illustrate?
Compare and contrast IM and SC injection routes: What factors would lead a clinician to choose one over the other for a specific medication?
Which three administration routes would be appropriate for an unconscious patient who cannot swallow, and what are the advantages and limitations of each?
A question describes two patches—one delivering fentanyl for chronic pain and one applying hydrocortisone for a local rash. Explain why these represent fundamentally different administration concepts despite both being applied to skin.
If an FRQ asks you to explain why the same drug might require different doses depending on administration route, which routes would demonstrate the greatest dose differences and why? (Hint: think about bioavailability and first-pass metabolism.)